World’s First Human Stem Cell Clinical Trial Approved by Japanese Government
By Ida Torres,
Japan Daily Press
| 07. 19. 2013
The Japanese government finally gave its approval for the world’s first clinical trials using stem cells that will be harvested from the patient’s body. Health Minister Norihisa Tamura gave permission for two research institutes to start their tests to treat age-related macular degeneration (AMD) by using “induced Pluripotent Stem (iPS) cells”.
The Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation (IBRI) Hospital in Kobe will be doing the joint testing to treat AMD, a condition that usually causes blindness among the elderly. This condition is incurable at the moment, and affects around 700,000 middle-aged to older people in Japan alone. Their proposal was
approved by a government committee last month, but they had to wait for the Health Ministry to sign off before starting the tests.
Riken will harvest the stem cells from the patients while IBRI will conduct the transplant by the middle of next year. The trial treatment will try
replacing the damaged part of the eye of six patients who have AMD with the retinal cells that will be created from the...
Related Articles
By Priyanka Runwal, Chemical and Engineering News | 08.05.2024
Saritee Sanodiya, 26, has spent countless days wondering if she’ll ever live a “normal” life. Growing up, Sanodiya often missed school, frequenting the hospital for sudden, life-threatening drops in her hemoglobin levels and excruciating pain in her joints. High fever...
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Alcott Wei, South China Morning Post | 07.13.2024
China has banned all clinical research involving germline genome editing under a newly released ethics guideline.
Germline gene engineering relates to altering the DNA in sperm, eggs or early embryos to introduce changes that can be inherited.
“Any clinical research...
By Staff, Japan Times | 07.10.2024
Photo by Roméo A. on Unsplash
How did Japanese society, which was supposed to have transformed into a democracy after World War II, justify discrimination against people with disabilities and openly endorse eugenics?
This is a key question people may...